Professur für Molekulare Mechanismen der Organfibrose

microRNA-145 mediates xylosyltransferase-I induction in myofibroblasts via suppression of transcription factor KLF4 (2020) Ly TD, Riedel L, Fischer B, Schmidt V, Hendig D, Distler J, Kuhn J, et al. Journal article Therapeutic molecular targets of SSc-ILD (2020) Zhang Y, Distler J Journal article Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis (2020) Soare A, Györfi AH, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, et al. Journal article Shared and distinct mechanisms of fibrosis (2019) Distler J, Györfi AH, Ramanujam M, Whitfield ML, Königshoff M, Lafyatis R Journal article, Review article GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways (2019) López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, et al. Journal article Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) Cavagna L, Trallero-Araguas E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, et al. Journal article Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis (2019) Kozlova A, Pachera E, Maurer B, Juengel A, Distler J, Kania G, Distler O Journal article Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution